Navigating data protection and cybersecurity in clinical trials
Guide for biotech and medtech companies
As biotech and medtech companies conduct clinical trials, safeguarding data privacy and cybersecurity become increasingly crucial. Failing to protect confidential and sensitive information can damage stakeholder trust, compromise the results of the study, and risk the safety and wellbeing of participants.
Helen Poliviou is the founder and managing director at PureCDM, a leading provider of high-quality clinical data services. Helen is answering your questions on data protection and cyber security in clinical trials.
Helen Poliviou
Helen Poliviou has worked in the life sciences sector for over 25 years and has dedicated the last 13 years supporting biotech and medtech innovation with leveraging technologies and data-driven strategies to optimize clinical trial operations.
Helen is a strong advocate of maintaining scientific rigor and integrity when conducting clinical trials and believes that organizations of all sizes and budgets should have access to high quality data services.
Under her leadership, PureCDM has been empowering start-up companies to navigate the complexities of clinical research, ultimately advancing the development of life-changing therapies and technologies for the benefit of patients worldwide.
1. What is data protection and why is it important in clinical trials?
Data protection is the process of safeguarding sensitive and confidential information from:
2. What laws and regulations govern data protection in clinical trials?
The regulations that govern data protection in clinical trials includes:
3. What is cybersecurity and why is it important in clinical trials?
Cybersecurity is the practice of protecting digital systems, networks, and sensitive data from cyber threats such as unauthorized access, hacking, and data breaches. In clinical trials, cybersecurity is crucial to protect high value data assets and the confidentiality and integrity of clinical trial data, which can contain sensitive personal and medical information. Failure to protect clinical trial data can compromise the safety and efficacy of the results, risk patient safety, and damage the reputation of the sponsor.
领英推荐
4. Who is responsible for data protection in clinical trials?
Sponsors are responsible for ensuring data protection in clinical trials, even if they outsource certain activities to a CRO or other vendors. The ICH GCP guideline states that sponsors must ensure that vendors and other parties involved in the study adhere to applicable regulations and guidelines related to data protection and cybersecurity. This includes providing oversight of vendor activities and ensuring that vendor contracts include provisions for data protection and cybersecurity.
5. What is the role of the EDC vendor in cybersecurity?
Electronic data capture (EDC) vendors play an essential role in clinical trials and in ensuring data protection and cybersecurity. They develop the technology and software necessary for electronic data capture, management, and reporting of clinical trial data.
EDC vendors are responsible for ensuring that the software they develop, and data hosting facilities meet regulatory requirements and industry best practices for data protection and cybersecurity. This includes design features that incorporate access controls, change control, electronic signature, data back-up and recovery, and monitoring tools to detect and prevent data breaches and other security incidents.
6. What is the role of clinical data management (CDM) in ensuring data protection in clinical trials?
CDM plays a crucial role in ensuring data protection and cybersecurity in clinical trials from:
7. What measures can biotech and medtech companies take to protect their clinical trial data?
8. Where is my clinical trial data stored?
Clinical trial data is stored securely in cloud-based or central data facilities managed by EDC vendors or third-party providers. Encryption is used to protect against unauthorized access or tampering during transit and storage. After study completion, the clinical database is archived, and data is returned to sponsors for secure storage. Sponsors may choose to store the data securely or have the EDC vendor store it for a fee.
For Australian companies, there are certain considerations to keep in mind when selecting a data storage facility. Ensure that offshore data centres comply with applicable data privacy laws and regulations. For example, if you have sites or partners in the EU, GDPR will apply and may include obtaining explicit consent from study participants for the transfer of their data to an offshore location.?Ensure appropriate measures are in place to securely encrypt the data during transfer and storage and that contractual arrangement clearly state data ownership and control.
Disclaimer: The information provided is for educational and informational purposes only and should not be construed as legal or professional advice. The laws and regulations surrounding data protection and cybersecurity in clinical trials vary by country and jurisdiction, and it is the responsibility of each company to ensure compliance with applicable laws and guidelines. This information should not be used as a substitute for consultation with qualified legal or professional advisors with expertise in data protection and cybersecurity.